Aevi Genomic Medicine (GNMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Operating Expenses | 8,251 | 8,735 | 7,160 | 8,569 | 8,036 |
| Operating Income | -8,251 | -8,735 | -7,160 | -8,569 | -8,036 |
| Other Income | 60 | 26 | 1 | -36 | 3 |
| Pre-tax Income | -8,191 | -8,709 | -7,159 | -8,605 | -8,033 |
| Net Income Continuous | -8,191 | -8,709 | -7,159 | -8,605 | -8,033 |
| Net Income | $-8,191 | $-8,709 | $-7,159 | $-8,605 | $-8,033 |
| EPS Basic Total Ops | -0.14 | -0.15 | -0.09 | -0.23 | -0.22 |
| EPS Basic Continuous Ops | -0.14 | -0.15 | -0.09 | -0.23 | -0.22 |
| EPS Diluted Total Ops | -0.14 | -0.15 | -0.09 | -0.23 | -0.22 |
| EPS Diluted Continuous Ops | -0.14 | -0.15 | -0.09 | -0.23 | -0.22 |
| EPS Diluted Before Non-Recurring Items | -0.14 | -0.15 | N/A | N/A | N/A |
| EBITDA(a) | $-8,235 | $-8,719 | $-7,144 | $-8,554 | $-7,996 |